Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus
BackgroundGastrointestinal (GI) symptoms are common in patients with type 2 diabetes mellitus (T2DM). Rebamipide is an effective gastric cytoprotective agent, but there are few data on its usefulness in T2DM. The aim of this study is to evaluate the improvement of GI symptoms after rebamipide treatm...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Diabetes Association
2016-04-01
|
Series: | Diabetes & Metabolism Journal |
Subjects: | |
Online Access: | https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-40-240.pdf |